A topical cream that helps regulate macrophage activity was effective in treating diabetic foot ulcers, a clinical trial reported. In 236 patients with foot ulcers treated for 16 weeks, the proportion ...
ON101 (Fespixon, Oneness Biotech), a first-in-class, macrophage-regulating, wound-healing cream for diabetic foot ulcers has shown benefit over absorbent dressings in a phase 3 trial, with another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback